Reyem Tech
Book a Call

How Reyem Tech helped Metrix Group secure funding and accelerate AI delivery | Case Study

Metrix Group brings deep domain expertise in pharma behavior-change and sales training, and wanted to evolve from a traditional services firm into an AI-enabled...
Pharma Marketing / Life-Sciences Training Metrix Group

How Reyem Tech helped Metrix Group secure funding and accelerate AI delivery

How Reyem Tech helped Metrix Group secure funding and accelerate AI delivery
Fractional CTO · ~1 year (2025–2026) · completed Engagement
DMAP (OCI) approved + SR&ED Funding secured
50–70% Report time reduction
Days → hours Workshop creation
6-person AI team Team built
Azure AKS + AWS, from zero Infrastructure
Neo4j graph + MCP server on K8s AI platform
18 identified · 6+ live AI workflows

The Challenge

Metrix Group brings deep domain expertise in pharma behavior-change and sales training, and wanted to evolve from a traditional services firm into an AI-enabled platform business. What it did not have was a technical foundation to build on:

  • No CTO or technical function — technology decisions were ad hoc.
  • No in-house developers — work was outsourced with no architectural oversight.
  • Zero cloud infrastructure — no dev environments, CI/CD, or scalable hosting.
  • Regulated-industry constraints — pharma clients require strict per-client data isolation; cross-client data sharing is legally prohibited.
  • A government digital-maturity funding opportunity on the table that required a credible technical strategy and documentation to unlock.
  • AI ambitions with no way to execute — no roadmap, platform, or team.

Our Solution

Reyem Tech embedded as a hands-on Fractional CTO (~15 hrs/week) for roughly a year, building Metrix's entire technology function from zero and concluding with a clean handover to permanent in-house leadership.

Pillar 1 — Securing funding. Led the DMAP (Digital Maturity Assessment Program) submission to the Ontario Centre of Innovation end-to-end — process-mapping every business area (Delivery, Sales, Marketing, Account Management, HR, and Finance), then authoring the assessment report, the AI-platform documentation, and the AI/data-architecture schematic. From process mapping in August 2025 to approval in January 2026, the submission secured government digital-maturity funding and validated the technical strategy. A second, non-dilutive channel was opened by structuring and supporting SR&ED R&D tax-credit applications for the AI work.

Pillar 2 — Accelerating AI delivery. At the core is a proprietary AI platform: a Neo4j knowledge graph as the analytics backbone — modeling behavior-change frameworks, stakeholder gaps, and evidence chains as a graph — on an ontology-first GraphRAG architecture, with a Model Context Protocol (MCP) server on Kubernetes (Python/FastMCP) exposing it to AI agents via ~20 tools, and per-client data isolation at every layer for pharma compliance.

From 18 identified AI workflows, the engagement drove a deploy-and-measure focus and shipped production tools that accelerate delivery:

  • An AI pipeline that turns interview transcripts into structured behavior-mapping tables via the knowledge graph — cutting analyst time by 50–70%.
  • AI-generated workshop materials (facilitator guides, activities, and slides) that take workshop creation from days to hours.
  • An AI-powered sales-training builder that assembles tailored learning paths, deployed for a global pharmaceutical client.
  • Augmented-reality training characters, deployed to production with reusable deployment tooling.
  • A learning-impact analytics dashboard for measuring training outcomes.

The platform runs on infrastructure built from zero — an Azure AKS production cluster, AWS for partner/tenant isolation with VPC peering, Airbyte ingestion into a medallion (Bronze/Silver/Gold) data lake, and a full Microsoft 365 migration — on a stack of self-hosted n8n, Azure OpenAI, Neo4j, Qdrant, and MongoDB.

To run it, Reyem Tech hired an AI developer and led a 6-person cross-functional team (developers, designers, and data specialists) on daily standups, Scrum, and a full SDLC — managing external suppliers and reducing bus-factor risk with knowledge-transfer plans, alongside security controls, DR planning, and pharma data separation validated by legal counsel.

The Results

Over roughly a year, the engagement built a durable, self-sufficient technology function — and left it running after a clean handover.

  • Government digital-maturity funding secured (DMAP approved, January 2026), plus a second channel opened via SR&ED R&D tax-credit applications.
  • 50–70% less analyst time on behavior-insights report generation; workshop creation cut from days to hours.
  • A full cloud + AI platform built from zero in ~1 year — Azure AKS + AWS, a medallion data lake, vector databases, a workflow engine, and an MCP server.
  • A Neo4j knowledge graph + MCP server in production — a proprietary, defensible capability inside a services business.
  • 18 AI workflows identified with a phased, deploy-and-measure rollout — 6+ in production by the end of the engagement.
  • A 6-person cross-functional AI team hired and productive on a structured SDLC.
  • Pharma compliance enforced architecturally — per-client isolation validated by legal counsel.
  • A durable handover — the engagement concluded with a clean transition to permanent in-house technical leadership; the platform, team, and processes kept running without disruption.
4.5 on Clutch
“I'm impressed by Reyem Technologies Inc's broad expertise, AI fluency, and positive, supportive leader.”
Jessica Knox
CEO, Metrix Group
Verified on Clutch

Ready to Achieve Similar Results?

Let's discuss how we can help transform your business.